Funder: METAvivor
Due Dates: February 5, 2025 (Portal Opens) | March 11, 2025 (Letter of Intent Due)
Funding Amounts: $450,000 total over 3 years for established investigators
Summary: Supports translational research to advance the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer.
Description
The METAvivor Translational Research Award provides substantial funding for established investigators conducting translational research focused on metastatic breast cancer. The award is designed to support projects that bridge laboratory discoveries and clinical application, with the ultimate goal of improving diagnosis, mechanistic understanding, and treatment of metastatic breast cancer (MBC). METAvivor is a nonprofit organization dedicated to accelerating research and improving outcomes for patients with advanced disease.
Due Dates
- Grant Portal Opens: February 5, 2025
- Required Letter of Intent Due: March 11, 2025
Applicants must submit a Letter of Intent (LOI) by the deadline to be eligible to submit a full proposal.
Funding Amount
- Total Award: $450,000
- Duration: 3 years
- Award Type: Grant
- Funding is intended for established investigators.
Eligibility
- Applicants must hold a clinical doctoral degree (e.g., MD, DO) or a doctoral degree (e.g., PhD) and be actively engaged in metastatic breast cancer research and/or treatment.
- The award is intended for established investigators; early career researchers should consider the separate Early Career Investigator Award.
- Open to researchers at academic, nonprofit, or medical institutions.
- There are no citizenship or geographic restrictions specified.
Application Process
- Letter of Intent (LOI):
- Submit an LOI via the METAvivor Grant Portal by March 11, 2025.
- Full Proposal:
- Selected applicants will be invited to submit a full proposal following LOI review.
- Application Materials:
- Q&A Session:
- A virtual Q&A for applicants was scheduled for February 10, 2025. Register here (link may be inactive after the event).
Eligibility
- Who can apply:
- Established investigators with a clinical or research doctoral degree (MD, PhD, or equivalent) actively engaged in metastatic breast cancer research.
- Institution types:
- Academic, nonprofit, or medical institutions.
- Citizenship:
- No explicit citizenship or residency restrictions.
Additional Information
- METAvivor also offers separate awards for early career investigators and quality of life research; see the METAvivor grant page for details.
- Patient advocate reviewers are involved in the review process.
- METAvivor has awarded over $37 million in research grants since 2009.
External Links
Contact Information